Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 6.36518836 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.36518836 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.03841269 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.75095703 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.55734252 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.55734252 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.42713656 |
8 | L-phenylalanine catabolic process (GO:0006559) | 5.38591845 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.38591845 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.23642005 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.23642005 |
12 | modulation by symbiont of host immune response (GO:0052553) | 5.23642005 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 5.23642005 |
14 | modulation by symbiont of host defense response (GO:0052031) | 5.23642005 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.23642005 |
16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.13888057 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.13792674 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.03543833 |
19 | detection of bacterium (GO:0016045) | 4.85179411 |
20 | detection of other organism (GO:0098543) | 4.84098536 |
21 | neutrophil activation involved in immune response (GO:0002283) | 4.78746567 |
22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77423482 |
23 | kynurenine metabolic process (GO:0070189) | 4.65766428 |
24 | aromatic amino acid family catabolic process (GO:0009074) | 4.64393971 |
25 | lysine metabolic process (GO:0006553) | 4.57784589 |
26 | lysine catabolic process (GO:0006554) | 4.57784589 |
27 | sulfur amino acid catabolic process (GO:0000098) | 4.51060477 |
28 | negative regulation of fibrinolysis (GO:0051918) | 4.40427600 |
29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37919146 |
30 | bile acid biosynthetic process (GO:0006699) | 4.37475923 |
31 | urea cycle (GO:0000050) | 4.35794008 |
32 | urea metabolic process (GO:0019627) | 4.35794008 |
33 | glyoxylate metabolic process (GO:0046487) | 4.35633893 |
34 | leukocyte aggregation (GO:0070486) | 4.34548833 |
35 | macrophage activation involved in immune response (GO:0002281) | 4.29774815 |
36 | negative regulation of sterol transport (GO:0032372) | 4.25914093 |
37 | negative regulation of cholesterol transport (GO:0032375) | 4.25914093 |
38 | cysteine metabolic process (GO:0006534) | 4.25836601 |
39 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.18672898 |
40 | regulation of cholesterol homeostasis (GO:2000188) | 4.16975490 |
41 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16918194 |
42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.11492014 |
43 | indole-containing compound catabolic process (GO:0042436) | 4.04501491 |
44 | indolalkylamine catabolic process (GO:0046218) | 4.04501491 |
45 | tryptophan catabolic process (GO:0006569) | 4.04501491 |
46 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.03315000 |
47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01556733 |
48 | glutamate metabolic process (GO:0006536) | 3.99974382 |
49 | nitrogen cycle metabolic process (GO:0071941) | 3.99306233 |
50 | response to peptidoglycan (GO:0032494) | 3.98210871 |
51 | regulation of cholesterol esterification (GO:0010872) | 3.97971486 |
52 | detection of external biotic stimulus (GO:0098581) | 3.94473697 |
53 | complement activation, alternative pathway (GO:0006957) | 3.92914712 |
54 | cellular modified amino acid catabolic process (GO:0042219) | 3.89849789 |
55 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.89350640 |
56 | regulation of protein activation cascade (GO:2000257) | 3.87587047 |
57 | response to interleukin-15 (GO:0070672) | 3.85421081 |
58 | phospholipid efflux (GO:0033700) | 3.85366944 |
59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83499636 |
60 | reverse cholesterol transport (GO:0043691) | 3.83046176 |
61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.81343009 |
62 | protein carboxylation (GO:0018214) | 3.81343009 |
63 | regulation of fibrinolysis (GO:0051917) | 3.77769515 |
64 | serine family amino acid catabolic process (GO:0009071) | 3.77578207 |
65 | oxygen transport (GO:0015671) | 3.76115730 |
66 | respiratory burst (GO:0045730) | 3.75252700 |
67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74171168 |
68 | negative regulation of phagocytosis (GO:0050765) | 3.71560610 |
69 | bile acid metabolic process (GO:0008206) | 3.70376456 |
70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67902775 |
71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.67118976 |
72 | tryptophan metabolic process (GO:0006568) | 3.63963087 |
73 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.63836204 |
74 | regulation of complement activation (GO:0030449) | 3.63458073 |
75 | regulation of triglyceride catabolic process (GO:0010896) | 3.61055743 |
76 | protein-lipid complex remodeling (GO:0034368) | 3.59364954 |
77 | macromolecular complex remodeling (GO:0034367) | 3.59364954 |
78 | plasma lipoprotein particle remodeling (GO:0034369) | 3.59364954 |
79 | homocysteine metabolic process (GO:0050667) | 3.56854357 |
80 | neutrophil activation (GO:0042119) | 3.56242530 |
81 | amino-acid betaine metabolic process (GO:0006577) | 3.56056699 |
82 | alpha-amino acid catabolic process (GO:1901606) | 3.53359113 |
83 | regulation of mast cell degranulation (GO:0043304) | 3.53304753 |
84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.50417109 |
85 | plasma lipoprotein particle clearance (GO:0034381) | 3.49998932 |
86 | negative regulation of interleukin-12 production (GO:0032695) | 3.49279254 |
87 | plasma lipoprotein particle assembly (GO:0034377) | 3.47559444 |
88 | glycine metabolic process (GO:0006544) | 3.47292344 |
89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45603000 |
90 | response to host immune response (GO:0052572) | 3.45603000 |
91 | regulation of leukocyte degranulation (GO:0043300) | 3.44817151 |
92 | aspartate family amino acid catabolic process (GO:0009068) | 3.44683830 |
93 | cellular response to interleukin-15 (GO:0071350) | 3.43558082 |
94 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43176582 |
95 | ethanol oxidation (GO:0006069) | 3.41726280 |
96 | detection of biotic stimulus (GO:0009595) | 3.39431546 |
97 | cellular amino acid catabolic process (GO:0009063) | 3.37764076 |
98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37315247 |
99 | protein-lipid complex assembly (GO:0065005) | 3.36832916 |
100 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.34280802 |
101 | detection of molecule of bacterial origin (GO:0032490) | 3.33301044 |
102 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.33084466 |
103 | aromatic amino acid family metabolic process (GO:0009072) | 3.31697125 |
104 | cellular ketone body metabolic process (GO:0046950) | 3.31004578 |
105 | cellular extravasation (GO:0045123) | 3.29423751 |
106 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.28785328 |
107 | cholesterol efflux (GO:0033344) | 3.28606462 |
108 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.27687203 |
109 | granulocyte activation (GO:0036230) | 3.26979648 |
110 | positive regulation of lipid catabolic process (GO:0050996) | 3.26612861 |
111 | response to host (GO:0075136) | 3.25869966 |
112 | response to host defenses (GO:0052200) | 3.25869966 |
113 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25869966 |
114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25472608 |
115 | drug catabolic process (GO:0042737) | 3.23318011 |
116 | triglyceride homeostasis (GO:0070328) | 3.22833527 |
117 | acylglycerol homeostasis (GO:0055090) | 3.22833527 |
118 | serine family amino acid metabolic process (GO:0009069) | 3.22692269 |
119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.21712426 |
120 | regulation of regulated secretory pathway (GO:1903305) | 3.20451955 |
121 | immunoglobulin mediated immune response (GO:0016064) | 3.19334710 |
122 | myeloid cell activation involved in immune response (GO:0002275) | 3.17949296 |
123 | type I interferon signaling pathway (GO:0060337) | 3.16653853 |
124 | cellular response to type I interferon (GO:0071357) | 3.16653853 |
125 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16211703 |
126 | signal complex assembly (GO:0007172) | 3.15207724 |
127 | response to type I interferon (GO:0034340) | 3.14746120 |
128 | gas transport (GO:0015669) | 3.10825284 |
129 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10685314 |
130 | coenzyme catabolic process (GO:0009109) | 3.09664619 |
131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09379022 |
132 | positive thymic T cell selection (GO:0045059) | 3.08958502 |
133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07382007 |
134 | serine family amino acid biosynthetic process (GO:0009070) | 3.06642094 |
135 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06129474 |
136 | B cell receptor signaling pathway (GO:0050853) | 3.05192292 |
137 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04088931 |
138 | oxaloacetate metabolic process (GO:0006107) | 3.03521084 |
139 | microglial cell activation (GO:0001774) | 3.01149354 |
140 | acetyl-CoA metabolic process (GO:0006084) | 3.01121053 |
141 | macrophage activation (GO:0042116) | 3.00639608 |
142 | dicarboxylic acid catabolic process (GO:0043649) | 3.00295172 |
143 | germinal center formation (GO:0002467) | 2.99646322 |
144 | regulation of T cell tolerance induction (GO:0002664) | 2.99406810 |
145 | negative regulation of type 2 immune response (GO:0002829) | 2.99248664 |
146 | benzene-containing compound metabolic process (GO:0042537) | 2.98484533 |
147 | sterol catabolic process (GO:0016127) | 2.98016899 |
148 | cholesterol catabolic process (GO:0006707) | 2.98016899 |
149 | valine metabolic process (GO:0006573) | 2.95718537 |
150 | neutrophil mediated immunity (GO:0002446) | 2.95670333 |
151 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.94418958 |
152 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.94418958 |
153 | response to muramyl dipeptide (GO:0032495) | 2.93675388 |
154 | modulation by virus of host process (GO:0019054) | 2.93208969 |
155 | arginine metabolic process (GO:0006525) | 2.93166043 |
156 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.92736601 |
157 | tricarboxylic acid metabolic process (GO:0072350) | 2.92732895 |
158 | phospholipid homeostasis (GO:0055091) | 2.92693833 |
159 | exogenous drug catabolic process (GO:0042738) | 2.92582587 |
160 | bile acid and bile salt transport (GO:0015721) | 2.90416653 |
161 | short-chain fatty acid metabolic process (GO:0046459) | 2.89600747 |
162 | negative regulation of cell size (GO:0045792) | 2.89398399 |
163 | leukocyte degranulation (GO:0043299) | 2.88577755 |
164 | negative regulation of lipid transport (GO:0032369) | 2.88567014 |
165 | plasma lipoprotein particle organization (GO:0071827) | 2.87195201 |
166 | regulation of platelet aggregation (GO:0090330) | 2.86761515 |
167 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.86473415 |
168 | tyrosine metabolic process (GO:0006570) | 2.86413442 |
169 | protein-lipid complex subunit organization (GO:0071825) | 2.84861362 |
170 | organic acid catabolic process (GO:0016054) | 2.84779457 |
171 | carboxylic acid catabolic process (GO:0046395) | 2.84779457 |
172 | ketone body metabolic process (GO:1902224) | 2.83968415 |
173 | imidazole-containing compound metabolic process (GO:0052803) | 2.83020525 |
174 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82897456 |
175 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82897456 |
176 | cytolysis (GO:0019835) | 2.81877234 |
177 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81277057 |
178 | complement activation, classical pathway (GO:0006958) | 2.81207172 |
179 | cholesterol homeostasis (GO:0042632) | 2.80912007 |
180 | positive regulation of mast cell activation (GO:0033005) | 2.80810349 |
181 | regulation of ARF protein signal transduction (GO:0032012) | 2.80754135 |
182 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.80530087 |
183 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.80319249 |
184 | modulation by symbiont of host cellular process (GO:0044068) | 2.80188328 |
185 | thymic T cell selection (GO:0045061) | 2.75245801 |
186 | positive regulation of fibroblast migration (GO:0010763) | 2.74162380 |
187 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.73406335 |
188 | regulation of tolerance induction (GO:0002643) | 2.72943621 |
189 | negative regulation of innate immune response (GO:0045824) | 2.72921219 |
190 | regulation of B cell differentiation (GO:0045577) | 2.71948553 |
191 | regulation of necroptotic process (GO:0060544) | 2.71752999 |
192 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70054932 |
193 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68343854 |
194 | negative thymic T cell selection (GO:0045060) | 2.67711141 |
195 | actin filament polymerization (GO:0030041) | 2.67652725 |
196 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.66868995 |
197 | positive regulation of Rap GTPase activity (GO:0032854) | 2.66431033 |
198 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64491389 |
199 | negative regulation of interleukin-6 production (GO:0032715) | 2.64353261 |
200 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.61758780 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.75948871 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.68366231 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.29207544 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.08719209 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35756867 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87125143 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83166313 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71243151 |
9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.68286946 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.57273556 |
11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.44011663 |
12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41660501 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32129690 |
14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.26950500 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.25625960 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18285681 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16179485 |
18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13597567 |
19 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11355733 |
20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.09337182 |
21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08748159 |
22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08178723 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.07508679 |
24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03546488 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02568969 |
26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94770527 |
27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91847753 |
28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90624071 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85825674 |
30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84559908 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83325948 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82058917 |
33 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80194110 |
34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79608370 |
35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77960968 |
36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.77607721 |
37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76975562 |
38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.76635858 |
39 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74481307 |
40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74445176 |
41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72975405 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67531239 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66351700 |
44 | P68_20966046_ChIP-Seq_HELA_Human | 1.65053159 |
45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64622488 |
46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64332650 |
47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62940946 |
48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59317437 |
49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.59062465 |
50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58943689 |
51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58414010 |
52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56539882 |
53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55407008 |
54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54785857 |
55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53600648 |
56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52774441 |
57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48993658 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46591299 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46509359 |
60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46227050 |
61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46041119 |
62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44291499 |
63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43666875 |
64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43519168 |
65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43154333 |
66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43152951 |
67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42413819 |
68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41768861 |
69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40280359 |
70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36045811 |
71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35962102 |
72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.35769478 |
73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35597500 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34734835 |
75 | MYB_26560356_Chip-Seq_TH2_Human | 1.34029275 |
76 | MYB_26560356_Chip-Seq_TH1_Human | 1.33597242 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32893940 |
78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32170464 |
79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30961601 |
80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30418642 |
81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29876555 |
82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29437086 |
83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27549908 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27477655 |
85 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27384073 |
86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27130860 |
87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26883034 |
88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26690434 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25543380 |
90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25360019 |
91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23251529 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23121409 |
93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20912440 |
94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20495029 |
95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19645831 |
96 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.18658723 |
97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18481874 |
98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17619188 |
99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17053273 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15709635 |
101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15636549 |
102 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14938673 |
103 | * MAF_26560356_Chip-Seq_TH1_Human | 1.14801409 |
104 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14047972 |
105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13393668 |
106 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13128660 |
107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12321909 |
108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.12173209 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11122838 |
110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11107034 |
111 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.11038405 |
112 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09879027 |
113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09639930 |
114 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09345441 |
115 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08573268 |
116 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07576334 |
117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07418023 |
118 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.07410249 |
119 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07009043 |
120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05627459 |
121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04501999 |
122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03621019 |
123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02151441 |
124 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01911415 |
125 | MAF_26560356_Chip-Seq_TH2_Human | 0.98329830 |
126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98266008 |
127 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.97683850 |
128 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97339201 |
129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96270309 |
130 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.96253162 |
131 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94405221 |
132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94234825 |
133 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92905872 |
134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91579210 |
135 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90234433 |
136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90183785 |
137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89306245 |
138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89169464 |
139 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89048362 |
140 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88257242 |
141 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88213910 |
142 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.87573496 |
143 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87510869 |
144 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86771907 |
145 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.86466582 |
146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86283518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.61708399 |
2 | MP0005360_urolithiasis | 6.06138192 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.91769440 |
4 | MP0005365_abnormal_bile_salt | 4.79013073 |
5 | MP0003436_decreased_susceptibility_to | 4.30439642 |
6 | MP0003724_increased_susceptibility_to | 4.06430935 |
7 | MP0009840_abnormal_foam_cell | 3.96176484 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.51704925 |
9 | MP0010329_abnormal_lipoprotein_level | 3.33981368 |
10 | MP0005083_abnormal_biliary_tract | 3.17906943 |
11 | MP0003705_abnormal_hypodermis_morpholog | 2.94108249 |
12 | MP0003252_abnormal_bile_duct | 2.93281200 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.89308936 |
14 | MP0002419_abnormal_innate_immunity | 2.89078578 |
15 | MP0001835_abnormal_antigen_presentation | 2.78099071 |
16 | MP0004859_abnormal_synaptic_plasticity | 2.77832266 |
17 | MP0008260_abnormal_autophagy | 2.68616788 |
18 | MP0005025_abnormal_response_to | 2.65953315 |
19 | MP0003806_abnormal_nucleotide_metabolis | 2.61438449 |
20 | MP0005387_immune_system_phenotype | 2.52155064 |
21 | MP0001790_abnormal_immune_system | 2.52155064 |
22 | MP0005000_abnormal_immune_tolerance | 2.46149889 |
23 | MP0002822_catalepsy | 2.45260166 |
24 | MP0001800_abnormal_humoral_immune | 2.33570569 |
25 | MP0006082_CNS_inflammation | 2.32387638 |
26 | MP0005332_abnormal_amino_acid | 2.29229278 |
27 | MP0001666_abnormal_nutrient_absorption | 2.28922965 |
28 | MP0005671_abnormal_response_to | 2.26040727 |
29 | MP0002420_abnormal_adaptive_immunity | 2.25551076 |
30 | MP0001819_abnormal_immune_cell | 2.22981533 |
31 | MP0009785_altered_susceptibility_to | 2.20901460 |
32 | MP0002723_abnormal_immune_serum | 2.17082826 |
33 | MP0001533_abnormal_skeleton_physiology | 2.07762445 |
34 | MP0003763_abnormal_thymus_physiology | 2.06905354 |
35 | MP0002452_abnormal_antigen_presenting | 2.02582306 |
36 | MP0000609_abnormal_liver_physiology | 1.95288332 |
37 | MP0003329_amyloid_beta_deposits | 1.91347056 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.90148963 |
39 | MP0002132_abnormal_respiratory_system | 1.88598421 |
40 | MP0005451_abnormal_body_composition | 1.86221973 |
41 | MP0002405_respiratory_system_inflammati | 1.81027292 |
42 | MP0002398_abnormal_bone_marrow | 1.80176951 |
43 | MP0003183_abnormal_peptide_metabolism | 1.79806760 |
44 | MP0010234_abnormal_vibrissa_follicle | 1.79729923 |
45 | MP0002148_abnormal_hypersensitivity_rea | 1.72751753 |
46 | MP0000604_amyloidosis | 1.72740715 |
47 | MP0003866_abnormal_defecation | 1.69057811 |
48 | MP0004510_myositis | 1.67918609 |
49 | MP0005319_abnormal_enzyme/_coenzyme | 1.67082800 |
50 | MP0000716_abnormal_immune_system | 1.66501484 |
51 | MP0004858_abnormal_nervous_system | 1.66342654 |
52 | MP0010155_abnormal_intestine_physiology | 1.65292815 |
53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64557334 |
54 | MP0003656_abnormal_erythrocyte_physiolo | 1.60455816 |
55 | MP0002396_abnormal_hematopoietic_system | 1.58516072 |
56 | MP0008961_abnormal_basal_metabolism | 1.57420889 |
57 | MP0002909_abnormal_adrenal_gland | 1.56263268 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.54167197 |
59 | MP0004130_abnormal_muscle_cell | 1.51547755 |
60 | MP0003075_altered_response_to | 1.48875350 |
61 | MP0003300_gastrointestinal_ulcer | 1.47150443 |
62 | MP0004019_abnormal_vitamin_homeostasis | 1.46942964 |
63 | MP0000858_altered_metastatic_potential | 1.45028226 |
64 | MP0004381_abnormal_hair_follicle | 1.44529061 |
65 | MP0002722_abnormal_immune_system | 1.42675565 |
66 | MP0001845_abnormal_inflammatory_respons | 1.42376922 |
67 | MP0003828_pulmonary_edema | 1.40017496 |
68 | MP0000703_abnormal_thymus_morphology | 1.39929606 |
69 | MP0002429_abnormal_blood_cell | 1.37903863 |
70 | MP0001851_eye_inflammation | 1.36242723 |
71 | MP0000689_abnormal_spleen_morphology | 1.33417285 |
72 | MP0003195_calcinosis | 1.31168235 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.27354234 |
74 | MP0003303_peritoneal_inflammation | 1.27079628 |
75 | MP0009643_abnormal_urine_homeostasis | 1.26844603 |
76 | MP0005167_abnormal_blood-brain_barrier | 1.21984087 |
77 | MP0002998_abnormal_bone_remodeling | 1.21861486 |
78 | MP0005310_abnormal_salivary_gland | 1.21811652 |
79 | MP0003868_abnormal_feces_composition | 1.17223667 |
80 | MP0000598_abnormal_liver_morphology | 1.15092211 |
81 | MP0002138_abnormal_hepatobiliary_system | 1.14240005 |
82 | MP0005377_hearing/vestibular/ear_phenot | 1.12992828 |
83 | MP0003878_abnormal_ear_physiology | 1.12992828 |
84 | MP0003172_abnormal_lysosome_physiology | 1.11184711 |
85 | MP0003566_abnormal_cell_adhesion | 1.08136615 |
86 | MP0008874_decreased_physiological_sensi | 1.07841637 |
87 | MP0005058_abnormal_lysosome_morphology | 1.06349727 |
88 | MP0000490_abnormal_crypts_of | 1.05174310 |
89 | MP0005464_abnormal_platelet_physiology | 1.04059062 |
90 | MP0001958_emphysema | 1.02915209 |
91 | MP0003635_abnormal_synaptic_transmissio | 1.02380163 |
92 | MP0005166_decreased_susceptibility_to | 1.01058250 |
93 | MP0004883_abnormal_blood_vessel | 1.00565875 |
94 | MP0008872_abnormal_physiological_respon | 0.94552014 |
95 | MP0005390_skeleton_phenotype | 0.94105470 |
96 | MP0003045_fibrosis | 0.93751665 |
97 | MP0005076_abnormal_cell_differentiation | 0.91343426 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.91281767 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.90834349 |
100 | MP0002078_abnormal_glucose_homeostasis | 0.88282858 |
101 | MP0005636_abnormal_mineral_homeostasis | 0.85530884 |
102 | MP0000920_abnormal_myelination | 0.85418014 |
103 | MP0002089_abnormal_postnatal_growth/wei | 0.84233563 |
104 | * MP0009642_abnormal_blood_homeostasis | 0.83871334 |
105 | MP0000343_altered_response_to | 0.83829241 |
106 | MP0003283_abnormal_digestive_organ | 0.83554294 |
107 | MP0001873_stomach_inflammation | 0.82867059 |
108 | MP0001663_abnormal_digestive_system | 0.81217433 |
109 | MP0005535_abnormal_body_temperature | 0.81166898 |
110 | MP0001756_abnormal_urination | 0.80778752 |
111 | MP0006036_abnormal_mitochondrial_physio | 0.80672177 |
112 | MP0003091_abnormal_cell_migration | 0.80659699 |
113 | MP0001764_abnormal_homeostasis | 0.79931234 |
114 | MP0002269_muscular_atrophy | 0.79180321 |
115 | MP0003879_abnormal_hair_cell | 0.76954831 |
116 | MP0002933_joint_inflammation | 0.75480777 |
117 | MP0005164_abnormal_response_to | 0.74900949 |
118 | MP0009780_abnormal_chondrocyte_physiolo | 0.74140926 |
119 | MP0001348_abnormal_lacrimal_gland | 0.73587270 |
120 | MP0003633_abnormal_nervous_system | 0.72581661 |
121 | MP0000747_muscle_weakness | 0.71650293 |
122 | MP0003448_altered_tumor_morphology | 0.71349735 |
123 | MP0003638_abnormal_response/metabolism_ | 0.70515556 |
124 | MP0004811_abnormal_neuron_physiology | 0.70230701 |
125 | MP0005666_abnormal_adipose_tissue | 0.70124132 |
126 | MP0002063_abnormal_learning/memory/cond | 0.69801326 |
127 | MP0005670_abnormal_white_adipose | 0.69110929 |
128 | MP0004808_abnormal_hematopoietic_stem | 0.69073275 |
129 | MP0005448_abnormal_energy_balance | 0.67152851 |
130 | MP0008469_abnormal_protein_level | 0.66742599 |
131 | MP0003279_aneurysm | 0.66330960 |
132 | MP0003795_abnormal_bone_structure | 0.66288978 |
133 | MP0001968_abnormal_touch/_nociception | 0.65736539 |
134 | MP0009763_increased_sensitivity_to | 0.64821176 |
135 | MP0001849_ear_inflammation | 0.64030855 |
136 | MP0005334_abnormal_fat_pad | 0.63923160 |
137 | MP0008569_lethality_at_weaning | 0.63330730 |
138 | MP0010352_gastrointestinal_tract_polyps | 0.62507994 |
139 | MP0002133_abnormal_respiratory_system | 0.62293217 |
140 | MP0005388_respiratory_system_phenotype | 0.62293217 |
141 | MP0000685_abnormal_immune_system | 0.61727287 |
142 | MP0008004_abnormal_stomach_pH | 0.60308492 |
143 | MP0002736_abnormal_nociception_after | 0.60180766 |
144 | MP0002970_abnormal_white_adipose | 0.60180080 |
145 | MP0002971_abnormal_brown_adipose | 0.59552209 |
146 | MP0002733_abnormal_thermal_nociception | 0.58792896 |
147 | MP0005375_adipose_tissue_phenotype | 0.58709811 |
148 | MP0009764_decreased_sensitivity_to | 0.57613966 |
149 | MP0002064_seizures | 0.57124520 |
150 | MP0004185_abnormal_adipocyte_glucose | 0.56922214 |
151 | MP0000639_abnormal_adrenal_gland | 0.56227352 |
152 | MP0000013_abnormal_adipose_tissue | 0.56224441 |
153 | MP0001765_abnormal_ion_homeostasis | 0.55887727 |
154 | MP0005220_abnormal_exocrine_pancreas | 0.55410606 |
155 | MP0004947_skin_inflammation | 0.54921327 |
156 | MP0003690_abnormal_glial_cell | 0.54852584 |
157 | MP0006035_abnormal_mitochondrial_morpho | 0.54082537 |
158 | MP0002136_abnormal_kidney_physiology | 0.54037901 |
159 | MP0009745_abnormal_behavioral_response | 0.53844101 |
160 | MP0008873_increased_physiological_sensi | 0.52469840 |
161 | MP0004270_analgesia | 0.51768915 |
162 | MP0009278_abnormal_bone_marrow | 0.51553971 |
163 | MP0009765_abnormal_xenobiotic_induced | 0.51429567 |
164 | MP0005023_abnormal_wound_healing | 0.51177586 |
165 | MP0000003_abnormal_adipose_tissue | 0.51129572 |
166 | MP0008770_decreased_survivor_rate | 0.50875046 |
167 | MP0003953_abnormal_hormone_level | 0.50773236 |
168 | MP0001545_abnormal_hematopoietic_system | 0.50631031 |
169 | MP0005397_hematopoietic_system_phenotyp | 0.50631031 |
170 | MP0009672_abnormal_birth_weight | 0.49347013 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypochromic microcytic anemia (HP:0004840) | 6.28293277 |
2 | Eczematoid dermatitis (HP:0000976) | 6.27930024 |
3 | Deep venous thrombosis (HP:0002625) | 5.60115506 |
4 | Recurrent abscess formation (HP:0002722) | 5.13251267 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.97750554 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.85958364 |
7 | Abnormality of macrophages (HP:0004311) | 4.79947627 |
8 | Myositis (HP:0100614) | 4.74880567 |
9 | Xanthomatosis (HP:0000991) | 4.63508079 |
10 | Hypochromic anemia (HP:0001931) | 4.59011255 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.45940240 |
12 | Orchitis (HP:0100796) | 4.31978277 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.28841036 |
14 | Intrahepatic cholestasis (HP:0001406) | 4.21191782 |
15 | Hypobetalipoproteinemia (HP:0003563) | 3.94573977 |
16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.82042142 |
17 | Obstructive lung disease (HP:0006536) | 3.82042142 |
18 | Stomatitis (HP:0010280) | 3.73665724 |
19 | Hyperlipoproteinemia (HP:0010980) | 3.69497450 |
20 | Complement deficiency (HP:0004431) | 3.68454906 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.67212228 |
22 | Optic neuritis (HP:0100653) | 3.67212228 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.60996778 |
24 | Increased IgE level (HP:0003212) | 3.58735310 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54353109 |
26 | Cellulitis (HP:0100658) | 3.51716974 |
27 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.48353198 |
28 | Ketosis (HP:0001946) | 3.43971237 |
29 | Hyperammonemia (HP:0001987) | 3.41560793 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.39230779 |
31 | Urticaria (HP:0001025) | 3.33720950 |
32 | Meningitis (HP:0001287) | 3.30746656 |
33 | Gingivitis (HP:0000230) | 3.29678355 |
34 | Spontaneous hematomas (HP:0007420) | 3.29209559 |
35 | Microcytic anemia (HP:0001935) | 3.24490441 |
36 | Prolonged bleeding time (HP:0003010) | 3.23929797 |
37 | Abnormality of the Achilles tendon (HP:0005109) | 3.11392058 |
38 | Recurrent fungal infections (HP:0002841) | 3.09451412 |
39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.09371632 |
40 | Abnormality of the lower motor neuron (HP:0002366) | 3.04768917 |
41 | Prolonged partial thromboplastin time (HP:0003645) | 3.03177449 |
42 | Hypolipoproteinemia (HP:0010981) | 3.02281444 |
43 | Recurrent skin infections (HP:0001581) | 3.01412900 |
44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98030654 |
45 | Myokymia (HP:0002411) | 2.92817840 |
46 | Neonatal onset (HP:0003623) | 2.88575741 |
47 | Abnormality of complement system (HP:0005339) | 2.85919459 |
48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.83961927 |
49 | Episodic fever (HP:0001954) | 2.83522317 |
50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79908772 |
51 | Hypoalphalipoproteinemia (HP:0003233) | 2.78337417 |
52 | Spastic diplegia (HP:0001264) | 2.76868687 |
53 | Encephalitis (HP:0002383) | 2.74010510 |
54 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72693949 |
55 | Gastrointestinal inflammation (HP:0004386) | 2.72308664 |
56 | Cholecystitis (HP:0001082) | 2.72138402 |
57 | Abnormal gallbladder physiology (HP:0012438) | 2.72138402 |
58 | Hyperglycinuria (HP:0003108) | 2.70855623 |
59 | Hyperglycinemia (HP:0002154) | 2.70434458 |
60 | Achilles tendon contracture (HP:0001771) | 2.69850261 |
61 | Keratoconjunctivitis sicca (HP:0001097) | 2.69549401 |
62 | Slow saccadic eye movements (HP:0000514) | 2.67162942 |
63 | Abnormality of glycine metabolism (HP:0010895) | 2.65137933 |
64 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65137933 |
65 | Chest pain (HP:0100749) | 2.64383883 |
66 | Inflammation of the large intestine (HP:0002037) | 2.64287177 |
67 | Gout (HP:0001997) | 2.64141571 |
68 | Hyperbilirubinemia (HP:0002904) | 2.62809513 |
69 | Vasculitis (HP:0002633) | 2.62802656 |
70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.62291783 |
71 | Epidermoid cyst (HP:0200040) | 2.62206566 |
72 | Ketoacidosis (HP:0001993) | 2.61161840 |
73 | Petechiae (HP:0000967) | 2.60835180 |
74 | Reticulocytosis (HP:0001923) | 2.59451448 |
75 | Hypercholesterolemia (HP:0003124) | 2.56095810 |
76 | Peritonitis (HP:0002586) | 2.55964012 |
77 | Cholelithiasis (HP:0001081) | 2.49909658 |
78 | Hypoglycemic coma (HP:0001325) | 2.45940500 |
79 | Abnormal hemoglobin (HP:0011902) | 2.45844838 |
80 | Insomnia (HP:0100785) | 2.45198546 |
81 | Joint hemorrhage (HP:0005261) | 2.44377604 |
82 | Delayed CNS myelination (HP:0002188) | 2.44171478 |
83 | Late onset (HP:0003584) | 2.42849239 |
84 | Epistaxis (HP:0000421) | 2.41612740 |
85 | Keratoconjunctivitis (HP:0001096) | 2.40439650 |
86 | Purpura (HP:0000979) | 2.38703111 |
87 | Polycythemia (HP:0001901) | 2.37479292 |
88 | Gingival bleeding (HP:0000225) | 2.35683705 |
89 | Hyperacusis (HP:0010780) | 2.35450924 |
90 | Distal upper limb amyotrophy (HP:0007149) | 2.35205844 |
91 | Upper limb amyotrophy (HP:0009129) | 2.35205844 |
92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.34534378 |
93 | Osteomyelitis (HP:0002754) | 2.33419152 |
94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.29386554 |
95 | Recurrent cutaneous fungal infections (HP:0011370) | 2.28888348 |
96 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.28888348 |
97 | Abnormal gallbladder morphology (HP:0012437) | 2.28763954 |
98 | Torticollis (HP:0000473) | 2.26195817 |
99 | Obstructive sleep apnea (HP:0002870) | 2.24702179 |
100 | Status epilepticus (HP:0002133) | 2.23932130 |
101 | Pustule (HP:0200039) | 2.23330214 |
102 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.23160784 |
103 | Global brain atrophy (HP:0002283) | 2.21273231 |
104 | Craniofacial dystonia (HP:0012179) | 2.20569843 |
105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20457104 |
106 | Fat malabsorption (HP:0002630) | 2.18493681 |
107 | Abnormality of the intrinsic pathway (HP:0010989) | 2.18119806 |
108 | Turricephaly (HP:0000262) | 2.17836295 |
109 | Malnutrition (HP:0004395) | 2.17615843 |
110 | Hepatocellular carcinoma (HP:0001402) | 2.16451468 |
111 | Hand muscle atrophy (HP:0009130) | 2.16120684 |
112 | Toxemia of pregnancy (HP:0100603) | 2.16088583 |
113 | Focal dystonia (HP:0004373) | 2.15886599 |
114 | Death in childhood (HP:0003819) | 2.15121342 |
115 | Sensorimotor neuropathy (HP:0007141) | 2.14177136 |
116 | Metaphyseal cupping (HP:0003021) | 2.13888334 |
117 | Mitral stenosis (HP:0001718) | 2.12017546 |
118 | Abnormal platelet volume (HP:0011876) | 2.11016089 |
119 | Sepsis (HP:0100806) | 2.09496000 |
120 | Abnormality of nucleobase metabolism (HP:0010932) | 2.09484868 |
121 | Colitis (HP:0002583) | 2.08752851 |
122 | Pulmonary embolism (HP:0002204) | 2.08438216 |
123 | Poikilocytosis (HP:0004447) | 2.08225942 |
124 | Pulmonary infiltrates (HP:0002113) | 2.06921102 |
125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06251353 |
126 | Anorexia (HP:0002039) | 2.03917983 |
127 | Hemoptysis (HP:0002105) | 2.01922969 |
128 | Polygenic inheritance (HP:0010982) | 2.01690681 |
129 | Increased cerebral lipofuscin (HP:0011813) | 2.01240856 |
130 | Arterial thrombosis (HP:0004420) | 2.00257575 |
131 | Back pain (HP:0003418) | 2.00171041 |
132 | Lymphopenia (HP:0001888) | 2.00162521 |
133 | Skin nodule (HP:0200036) | 1.99905562 |
134 | Abnormality of purine metabolism (HP:0004352) | 1.99534025 |
135 | Abnormality of methionine metabolism (HP:0010901) | 1.99027623 |
136 | Acanthocytosis (HP:0001927) | 1.98462609 |
137 | Supranuclear gaze palsy (HP:0000605) | 1.97362405 |
138 | Difficulty running (HP:0009046) | 1.96655751 |
139 | Hepatosplenomegaly (HP:0001433) | 1.96521667 |
140 | Long toe (HP:0010511) | 1.95982593 |
141 | Systemic lupus erythematosus (HP:0002725) | 1.95140870 |
142 | Loss of speech (HP:0002371) | 1.95103293 |
143 | Myocardial infarction (HP:0001658) | 1.94984000 |
144 | Recurrent viral infections (HP:0004429) | 1.93508015 |
145 | Lymphangioma (HP:0100764) | 1.91577290 |
146 | Nasal polyposis (HP:0100582) | 1.91512343 |
147 | Increased IgM level (HP:0003496) | 1.91337662 |
148 | Generalized hyperpigmentation (HP:0007440) | 1.90976871 |
149 | Diplopia (HP:0000651) | 1.90117361 |
150 | Abnormality of binocular vision (HP:0011514) | 1.90117361 |
151 | Increased serum ferritin (HP:0003281) | 1.89142045 |
152 | Cerebral aneurysm (HP:0004944) | 1.87160219 |
153 | Hypergammaglobulinemia (HP:0010702) | 1.86226394 |
154 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86100933 |
155 | Myoglobinuria (HP:0002913) | 1.85589073 |
156 | Abnormality of the peritoneum (HP:0002585) | 1.85045362 |
157 | Hypermelanotic macule (HP:0001034) | 1.84215339 |
158 | Acne (HP:0001061) | 1.84106596 |
159 | Amyloidosis (HP:0011034) | 1.83985674 |
160 | Ankle clonus (HP:0011448) | 1.83630103 |
161 | Leukocytosis (HP:0001974) | 1.83550883 |
162 | Abnormality of the pericardium (HP:0001697) | 1.83285920 |
163 | Increased connective tissue (HP:0009025) | 1.82569075 |
164 | Abnormality of the gallbladder (HP:0005264) | 1.80930424 |
165 | Premature loss of primary teeth (HP:0006323) | 1.80850219 |
166 | Annular pancreas (HP:0001734) | 1.80441817 |
167 | Visual hallucinations (HP:0002367) | 1.80162088 |
168 | Abnormal cartilage morphology (HP:0002763) | 1.79980321 |
169 | Granulocytopenia (HP:0001913) | 1.79858260 |
170 | Interstitial pulmonary disease (HP:0006530) | 1.79593663 |
171 | Impaired social interactions (HP:0000735) | 1.78843203 |
172 | Abnormal social behavior (HP:0012433) | 1.78843203 |
173 | Skin ulcer (HP:0200042) | 1.78548247 |
174 | Gastrointestinal stroma tumor (HP:0100723) | 1.77952616 |
175 | Panhypogammaglobulinemia (HP:0003139) | 1.77539103 |
176 | Hypertriglyceridemia (HP:0002155) | 1.77466613 |
177 | Stroke (HP:0001297) | 1.77078849 |
178 | Renovascular hypertension (HP:0100817) | 1.76903959 |
179 | Irritability (HP:0000737) | 1.76105816 |
180 | Neuronal loss in central nervous system (HP:0002529) | 1.75859617 |
181 | Elfin facies (HP:0004428) | 1.75145606 |
182 | Abnormality of the nasal mucosa (HP:0000433) | 1.75098213 |
183 | Esophageal varix (HP:0002040) | 1.75089409 |
184 | T lymphocytopenia (HP:0005403) | 1.74722385 |
185 | Hemiplegia (HP:0002301) | 1.74665035 |
186 | Cerebral inclusion bodies (HP:0100314) | 1.73803114 |
187 | Hemorrhage of the eye (HP:0011885) | 1.72346832 |
188 | Glomerulopathy (HP:0100820) | 1.71231281 |
189 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70495752 |
190 | Growth hormone excess (HP:0000845) | 1.70242756 |
191 | Abnormality of iron homeostasis (HP:0011031) | 1.68267500 |
192 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67945510 |
193 | Atrioventricular block (HP:0001678) | 1.67879188 |
194 | Metabolic acidosis (HP:0001942) | 1.66504020 |
195 | Depression (HP:0000716) | 1.64793023 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.10289249 |
2 | RIPK4 | 4.26051095 |
3 | PKN2 | 4.23085830 |
4 | ERN1 | 2.99084792 |
5 | PRPF4B | 2.93382961 |
6 | BCKDK | 2.84845785 |
7 | EEF2K | 2.66541543 |
8 | IRAK4 | 2.53603400 |
9 | KSR2 | 2.50823378 |
10 | MAP3K10 | 2.50306312 |
11 | SIK1 | 2.24664987 |
12 | MAP3K9 | 2.23709910 |
13 | DAPK2 | 2.10607164 |
14 | MAP3K3 | 2.10104596 |
15 | SMG1 | 2.01144616 |
16 | CSK | 1.96867653 |
17 | CAMKK1 | 1.87842942 |
18 | RIPK1 | 1.86194492 |
19 | FGFR4 | 1.86116888 |
20 | TAOK1 | 1.80570443 |
21 | SCYL2 | 1.78310999 |
22 | TAOK2 | 1.70922988 |
23 | EPHA4 | 1.58830480 |
24 | PTK6 | 1.55116263 |
25 | NEK1 | 1.55083043 |
26 | GRK6 | 1.47942468 |
27 | PRKD3 | 1.46541299 |
28 | FGR | 1.44989645 |
29 | SIK2 | 1.40087921 |
30 | PRKD2 | 1.36763006 |
31 | BTK | 1.34446190 |
32 | PAK6 | 1.33450591 |
33 | RET | 1.33031047 |
34 | MAP3K7 | 1.32396636 |
35 | ICK | 1.32128444 |
36 | MAP4K1 | 1.30626720 |
37 | SIK3 | 1.26031633 |
38 | NTRK1 | 1.24489497 |
39 | LMTK2 | 1.24487254 |
40 | * HCK | 1.20894000 |
41 | LRRK2 | 1.19762480 |
42 | MAP3K11 | 1.19277602 |
43 | PDGFRA | 1.16621591 |
44 | BMX | 1.15884206 |
45 | MAP2K4 | 1.15553627 |
46 | JAK3 | 1.15073977 |
47 | SYK | 1.13011647 |
48 | ALK | 1.11974480 |
49 | DAPK1 | 1.11938537 |
50 | MAP3K2 | 1.10643632 |
51 | FLT3 | 1.09211116 |
52 | TESK2 | 1.02570653 |
53 | NTRK3 | 0.99091916 |
54 | MINK1 | 0.99031618 |
55 | MAPK11 | 0.98521537 |
56 | PRKCH | 0.97820296 |
57 | CDK19 | 0.97541276 |
58 | MAP3K13 | 0.92334951 |
59 | MAP3K1 | 0.90930507 |
60 | DAPK3 | 0.88912205 |
61 | TYRO3 | 0.87697555 |
62 | STK38 | 0.87683027 |
63 | JAK2 | 0.85856466 |
64 | LYN | 0.85069330 |
65 | KSR1 | 0.83624717 |
66 | IKBKE | 0.81092771 |
67 | PDPK1 | 0.80829467 |
68 | KDR | 0.80206869 |
69 | PDK1 | 0.79018559 |
70 | MAPKAPK3 | 0.78478086 |
71 | ARAF | 0.77239111 |
72 | LCK | 0.76796760 |
73 | TBK1 | 0.75238185 |
74 | TTN | 0.74491017 |
75 | MAP2K1 | 0.73668338 |
76 | HIPK2 | 0.72833876 |
77 | CDC42BPA | 0.71723317 |
78 | PTK2B | 0.70994560 |
79 | CSF1R | 0.70134431 |
80 | PAK4 | 0.68451376 |
81 | IRAK2 | 0.67603494 |
82 | MAP3K6 | 0.67520002 |
83 | FYN | 0.67074624 |
84 | JAK1 | 0.65242113 |
85 | PINK1 | 0.65052471 |
86 | PTK2 | 0.64289551 |
87 | MAP2K2 | 0.63941804 |
88 | DYRK1B | 0.63788391 |
89 | YES1 | 0.63652603 |
90 | RAF1 | 0.63578599 |
91 | MARK3 | 0.63492043 |
92 | PRKCZ | 0.62455148 |
93 | MAP2K3 | 0.61793870 |
94 | FES | 0.59960956 |
95 | RPS6KA2 | 0.59295517 |
96 | MARK2 | 0.58055082 |
97 | MAP3K4 | 0.57902465 |
98 | TNK2 | 0.57899701 |
99 | MAP3K14 | 0.56618325 |
100 | ITK | 0.56128505 |
101 | RPS6KL1 | 0.54674414 |
102 | RPS6KC1 | 0.54674414 |
103 | TYK2 | 0.53815572 |
104 | TESK1 | 0.52081172 |
105 | ZAP70 | 0.51950862 |
106 | CDK5 | 0.51226943 |
107 | SGK3 | 0.51064119 |
108 | ILK | 0.50860395 |
109 | MTOR | 0.47605408 |
110 | MAP2K6 | 0.46361760 |
111 | TXK | 0.46022919 |
112 | CAMK4 | 0.45784273 |
113 | GRK5 | 0.45639617 |
114 | LATS2 | 0.45406578 |
115 | KIT | 0.43122352 |
116 | MAP3K8 | 0.42946813 |
117 | MAPK7 | 0.42685245 |
118 | UHMK1 | 0.42157519 |
119 | CDK12 | 0.42027647 |
120 | ERBB2 | 0.41509163 |
121 | STK10 | 0.41195294 |
122 | STK11 | 0.40282373 |
123 | PRKG2 | 0.39641111 |
124 | DDR2 | 0.39590431 |
125 | NEK2 | 0.39289989 |
126 | RPS6KA6 | 0.38858497 |
127 | EPHB1 | 0.38838375 |
128 | BRAF | 0.38601903 |
129 | IRAK3 | 0.37357186 |
130 | NTRK2 | 0.36935463 |
131 | MAPK12 | 0.36821381 |
132 | BLK | 0.35662392 |
133 | PRKCG | 0.35065236 |
134 | PHKG2 | 0.34429229 |
135 | PHKG1 | 0.34429229 |
136 | CAMK1 | 0.33259176 |
137 | RPS6KA1 | 0.31937556 |
138 | MATK | 0.31758519 |
139 | PRKD1 | 0.31417094 |
140 | CDK15 | 0.31065662 |
141 | PRKAA1 | 0.31040151 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.67874401 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.85631418 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84611527 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.22656611 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86321155 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63707863 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40033956 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36703079 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.28621460 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24811558 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22907666 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13356224 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12146215 |
14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06921308 |
15 | Bile secretion_Homo sapiens_hsa04976 | 1.96416068 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.91884062 |
17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.90892542 |
18 | Malaria_Homo sapiens_hsa05144 | 1.89362912 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88291001 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.87264391 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81818539 |
22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.78252617 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75365916 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74365270 |
25 | Tuberculosis_Homo sapiens_hsa05152 | 1.71744031 |
26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69106174 |
27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62451740 |
28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59775931 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56171240 |
30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50114626 |
31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49661488 |
32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46349031 |
33 | Allograft rejection_Homo sapiens_hsa05330 | 1.46026971 |
34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.45843173 |
35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41601207 |
36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40866140 |
37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39971022 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39888183 |
39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39201402 |
40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39120370 |
41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37623308 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37236910 |
43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36156918 |
44 | Peroxisome_Homo sapiens_hsa04146 | 1.31708714 |
45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29558022 |
46 | Measles_Homo sapiens_hsa05162 | 1.28892008 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28443845 |
48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28382457 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28325100 |
50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27388668 |
51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26082884 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26069332 |
53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25456690 |
54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21984220 |
55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19517543 |
56 | Endocytosis_Homo sapiens_hsa04144 | 1.17137304 |
57 | Phagosome_Homo sapiens_hsa04145 | 1.16134190 |
58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13909330 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13640629 |
60 | Influenza A_Homo sapiens_hsa05164 | 1.12378192 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11266464 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10808138 |
63 | Platelet activation_Homo sapiens_hsa04611 | 1.09774772 |
64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06583639 |
65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06484307 |
66 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06107616 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 1.06012492 |
68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05044605 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.04151192 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03367396 |
71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02753255 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02591838 |
73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02282387 |
74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01116680 |
75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00669437 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00339158 |
77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00277943 |
78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99191434 |
79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99071620 |
80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98636829 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98481711 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98236966 |
83 | Shigellosis_Homo sapiens_hsa05131 | 0.98059704 |
84 | Salmonella infection_Homo sapiens_hsa05132 | 0.97490079 |
85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97206476 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97133500 |
87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96740263 |
88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95787169 |
89 | Hepatitis B_Homo sapiens_hsa05161 | 0.95249275 |
90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93301277 |
91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93186198 |
92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92390522 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92147304 |
94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91376458 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89461161 |
96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89263304 |
97 | Apoptosis_Homo sapiens_hsa04210 | 0.88026660 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85257887 |
99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84801162 |
100 | Lysine degradation_Homo sapiens_hsa00310 | 0.83272642 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82287360 |
102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81112864 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80842304 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80342945 |
105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79355782 |
106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79331589 |
107 | Legionellosis_Homo sapiens_hsa05134 | 0.77630976 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76370756 |
109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74581645 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74358159 |
111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74234757 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.72937835 |
113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72909127 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.71945261 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.71222127 |
116 | Pertussis_Homo sapiens_hsa05133 | 0.69990601 |
117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69492410 |
118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69175805 |
119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68038180 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67677844 |
121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67663301 |
122 | Lysosome_Homo sapiens_hsa04142 | 0.67083209 |
123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65421016 |
124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64306518 |
125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64194759 |
126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62525371 |
127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62472235 |
128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62118557 |
129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61848795 |
130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59905172 |
131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58142833 |
132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56700723 |
133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56685566 |
134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56198340 |
135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55902487 |
136 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55485076 |
137 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55387033 |
138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55292004 |
139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54837944 |
140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53806507 |
141 | Bladder cancer_Homo sapiens_hsa05219 | 0.53728012 |
142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52907065 |
143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51367796 |
144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50824304 |
145 | Glioma_Homo sapiens_hsa05214 | 0.50032884 |
146 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49193111 |
147 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48402925 |
148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47170748 |
149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46723919 |
150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46529487 |
151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45527246 |
152 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45328061 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44961959 |
154 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36067628 |
155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35460517 |
156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34931915 |
157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31664074 |
158 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31641317 |
159 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31151032 |
160 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29504243 |
161 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29477775 |
162 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28152449 |
163 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26384389 |
164 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25750265 |
165 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25286598 |
166 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25205078 |
167 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24160920 |
168 | Insulin secretion_Homo sapiens_hsa04911 | 0.24014032 |
169 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23907847 |
170 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22075921 |
171 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21483859 |
172 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21469132 |
173 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20394056 |